Results 231 to 240 of about 82,995 (291)

Preconception Health Indicators and Deprivation: A Cross‐Sectional Study Using National Maternity Healthcare Data

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To use routinely‐collected maternity healthcare data to (1) describe the prevalence of key preconception indicators (e.g., smoking, folic acid supplement use) and (2) explore differences in prevalence by deprivation. Design Retrospective population‐based study. Setting Northern Ireland (NI). Population 255 177 pregnancies recorded in
Emma H. Cassinelli   +5 more
wiley   +1 more source

Anesthetic Management of the Pregnant Patient Undergoing Non-Obstetric Surgery. [PDF]

open access: yesMedicina (Kaunas)
Monanian G   +5 more
europepmc   +1 more source

Women's Childbirth Experiences in the WILL Randomised Trial (When to Induce Labour to Limit Risk in Pregnancy Hypertension): A Mixed Methods Analysis

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To compare childbirth satisfaction in women with chronic or gestational hypertension, randomised to ‘planned early term birth at 38+0–3 weeks' gestation’ (intervention) or ‘usual care at term’ (control). Design Randomised trial. Setting Forty‐two consultant‐led maternity units, United Kingdom.
Sue Tohill   +13 more
wiley   +1 more source

Economic Impact of Severe Early‐Onset Foetal Growth Restriction: A Multicentre Prospective Cohort Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective Foetal growth restriction (FGR) affects 10% of pregnancies, contributing to 30% of stillbirths. Current management of early‐onset FGR (< 32 + 0 weeks' gestation) delivers the foetus before stillbirth or irreversible organ damage. The resulting preterm births create additional risks independent of FGR.
George Bray   +20 more
wiley   +1 more source

Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy

open access: yesThe American Journal on Addictions, EarlyView.
Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage   +3 more
wiley   +1 more source

The impact of using cannabis during pregnancy on the infant and mother: An overview of systematic reviews, evidence map, targeted updates, and de novo synthesis

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
Background Cannabis use during pregnancy is becoming more prevalent. While numerous studies have explored the relationship of cannabis use during pregnancy and outcomes for mothers and infants, uncertainty remains regarding the impact of cannabis use on pregnancy complications and later‐life outcomes for offspring.
Zachary Munn   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy